Owen, best known as a pioneer of breakfast TV and his partnership with Anne Diamond, said he had had no symptoms and the diagnosis had "come out of the blue". He revealed he had had a prostate-specific antigen (PSA) blood test which had shown slightly elevated results.

PCF funds the world's most promising research to improve the prevention, detection and treatment of prostate cancer and ultimately cure it for good.

There is no cure for metastatic prostate cancer, but it is often treatable for quite some time. Many people outlive their prostate cancer, even those who have advanced disease. Often, the prostate cancer grows slowly, and there are now effective treatment options that extend life even further.

The 5-year relative survival rate for most people with local or regional prostate cancer is nearly 100%. For people diagnosed with prostate cancer that has spread to other parts of the body, the 5-year relative survival rate is 32%. Experts measure relative survival rate statistics for prostate cancer every 5 years.

High Cure Rates for Local and Regional Prostate Cancers Approximately 80 percent to 85 percent of all prostate cancers are detected in the local or regional stages, which represent stages I, II and III. Many men diagnosed and treated at the local or regional stages will be disease-free after five years.

Targeted radiation therapy and PSMA This new compound can potentially find, bind to, and kill prostate cancer cells throughout the body. In a recent clinical trial, men with a type of advanced prostate cancer who received a PSMA-targeting drug lived longer than those who received standard therapies.

The prostate can regenerate when androgen is restored. A team of researchers led by Dr. Charles Sawyers of Memorial Sloan Kettering Cancer Center and Aviv Regev at the Broad Institute studied how normal prostate tissue restores itself after androgen deprivation therapy.

General Prostate Cancer Survival Rate The relative 5-year survival rate is nearly 100% The relative 10-year survival rate is 98% The 15-year relative survival rate is 91%

The short answer is yes, prostate cancer can be cured, when detected and treated early. The vast majority of prostate cancer cases (more than 90 percent) are discovered in the early stages, making the tumors more likely to respond to treatment. Treatment doesn't always have to mean surgery or chemotherapy, either.

The 10-year relative survival rate is 98%. The survival rates for prostate cancer vary based on several factors. These include the stage and grade of the cancer, a person's age and general health, and how well the treatment plan works. Another factor that can affect outcomes is the type of prostate cancer.

The outlook for people with BPH is very good. BPH doesn't have a cure, but treatments can help alleviate your symptoms. Mild symptoms may not require treatment. Medications, surgery and minimally invasive treatments can treat more severe cases.

The approval, announced on June 20, makes talazoparib the third PARP-blocking drug to be cleared by the agency to treat prostate cancer. FDA based the approval on a set of data from a large, randomized phase 3 clinical trial called TALAPRO-2 - funded by Pfizer, the maker of talazoparib.